[Skip to Content]
[Skip to Content Landing]
Article
May 1969

The Isolation of Neurons From Normal and Abnormal Human Cerebral Cortex

Author Affiliations

Stanford, Calif
From the departments of pediatrics and human development (Drs. McKhann and Ho), and genetics (Mr. Raiborn and Dr. Varon), Lt. Joseph P. Kennedy, Jr. Laboratories for Molecular Medicine, Stanford University School of Medicine, Stanford, Calif. Dr. McKhann is now with the Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, and Mr. Raiborn and Dr. Varon are now with the Department of Biology, University of California at San Diego, La Jolla, Calif.

Arch Neurol. 1969;20(5):542-547. doi:10.1001/archneur.1969.00480110106011
Abstract

AMONG the degenerative diseases of the nervous system of metabolic origin, there is a group of conditions in which substances accumulate to excess within neurons. In some of these processes, the nature of the stored material has been well characterized. In Tay-Sachs disease, the accumulation of a particular ganglioside is well-documented. Recently, there have been suggestions about the nature of the enzymatic defect; for example, the dysfunction of a catabolic enzyme, a lipid hexoseaminidase1 (oral communication, with L. Svennerholm, MD, May 1968). In other diseases, the fact that there is storage of some material is well-documented, but the composition of the stored material and the nature of the metabolic defect is not known. An example of this type of disease is the late infantile form of neuronal storage disease.

The study of the neuronal storage diseases is handicapped by the fact that not all cells show the storage

First Page Preview View Large
First page PDF preview
First page PDF preview
×